It’s time for comprehensive genetic testing of the germ line in breast cancer

A new study provides additional support for comprehensive germline genetic testing of affected women breast cancer. The study found that adherence to current restrictive guidelines on germline testing is missed by a significant number of women with pathogenic or potentially pathogenic (P/LP) variants, which would alter patient management. The study used a polygenic cancer panel … Read more

More false than true positive

Dr. Deborah Schrag PARIS – New results from a large future trial are giving a better idea of ​​how a blood test that can detect many cancers performs in a “real-life” environment. “As this technology develops, people should continue to have standard cancer screening, but this is a glimpse of what the future may hold,” … Read more